Table 4.
Past 30-Day Use of Highest Scoring Drug (HSDa) at Follow-up as a Function of Drug Type
| Number of Drug Use Days, Past 30 Days, at Follow- up | ||||
|---|---|---|---|---|
| HSD Drug Type | Control Group meanb (n) | Intervention Group meanb (n) | Group Difference | 95% CI |
| Cannabis | 11.72 (68) | 9.22 (69) | 2.51 | -0.34, 5.35 |
| Cocaine/Crack | 6.16 (20) | 3.39 (30) | 2.77 | -0.08, 5.63 |
| Methamphetamine/Amphetamine-Type Stimulants | 6.86 (14) | 6.85 (14) | 0.01 | -7.57, 7.58 |
| Sedatives | 9.40 (16) | 5.20 (8) | 4.19 | -2.92, 11.31 |
| Opiates | 11.63 (12) | 3.81 (8) | 7.82 | -0.44, 16.08 |
Highest scoring drug in problem range (4–26) on WHO ASSIST
Adjusted for baseline HSD use (NOTE: due to small sample sizes none of these results are significant, so no p values are shown)HKVB